Neurocentria. Discovery and Clinical stage development of innovative therapeutics for Neurological Disorders - www.neurocentria.com
Neurocentria. Discovery and Clinical stage development of innovative therapeutics for Neurological Disorders - www.neurocentria.com
What’s new on Neurocentria.com: Check updates and related news right now. This site’s feed is stale or rarely updated (or it might be broken for a reason), but you may check related news or Neurocentria.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.
Kyle J. Norton (Scholar) Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news...
By Jason Napodano, CFA We recently sat down with Amarantus Bioscience Holdings (AMBS) CEO, Gerald Commissiong. The meeting confirmed our belief that Amarantus is in the midst of a fundamental turnaround and has significant growth potential over the...
This is an article written by Dana Ullman and published. http://www.huffingtonpost.com/dana-ullman/dysfunction-at-wikipedia-_b_5924226.html I think Dana Ullman summarised the situation well here in 2014. Unfortunately the issue continues and even has...
Innov Clin Neurosci. 2015;12(5–6 Suppl B):3–19 Click here to access the e-Edition, a digital replica of the printed version. CNS Drug Compounds/Therapies/Devices Long-acting injectable antipsychotics (LAIs) in outpatient treatment of DMS-IV-R schizophrenia...
spiked-online 18 November 2005 The Great Cholesterol Myth We all know that a high cholesterol diet is bad for you, right? Wrong, says this medical writer. by Malcolm Kendrick If you eat too much cholesterol, or saturated fat, your blood cholesterol...
SOCRATES is an international, refereed (peer-reviewed) and indexed scholarly hybrid open-access journal in Public Administration a...
Managing Myeloma is an educational initiative dedicated to developing tools, information, and resources that support improved ther...
Home page | Orphanet Journal of Rare Diseases
Encompassing all aspects of rare diseases and orphan drugs, Orphanet Journal of Rare Diseases features high quality reviews and or...
synaptogenesis and enhance synaptic function Through molecular screening, we identified a novel compound that can selectively elevate intracellular magnesium at the synaptic terminal. In vivo, this co...
Improves Brain Age by 9 Years in Human Study on Older Adults Data from double-blind placebo-controlled clinical trial, now published in the Journal of Alzheimer’s Disease, supports ongoing studies in ...
Partnering At NEUROCENTRIA, we are dedicated to bringing innovative medicines to patients with cognitive impairment disorders. We are committed to partnerships and collaborations to expand access to o...
10 years
Domain age
N/A
Visit duration
252
Daily visitors
N/A
Bounce rate